Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-40.22M.
ENTERPRISE VALUE (EV)
$-40.22M
Pasithea Therapeutics Corp.
Market Cap
$14.94M
Enterprise Value (EV)
$-40.22M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $14.94M | $-40.22M |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | $175.63M |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | $14.48M |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | $6.59M |
| Jin Medical International Ltd. (ZJYL)vs › | $15.58M | $27.07M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | $20.98M |
| BioCardia, Inc. (BCDA)vs › | $15.78M | $11.95M |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | $10.92M |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | $13.32M |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A |
Market Cap
$14.94M
Total Debt
$0.00
Cash
$55.16M
Enterprise Value
$-40.22M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
